ArticleParasites & vectors2025

Identification of a moxidectin dose for 4- to 11-year-old children to support registration and potential use for onchocerciasis elimination: results of an open-label pharmacokinetic and safety study.

Nicholas O Opoku et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.